GetTopicDetailResponse(id=356e125e7617, topicName=Solbinsiran, introduction=, content=混合性血脂異常 Solbinsiran, image=null, comments=0, allHits=99, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Apr 05 22:15:14 CST 2025, time=2025-04-05, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=503245, tagList=[TagDto(tagId=503245, tagName=Solbinsiran)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2259261, encodeId=00c0225926153, content=<a href='/topic/show?id=c5a16618995' target=_blank style='color:#2F92EE;'>#混合性血脂異常#</a> <a href='/topic/show?id=356e125e7617' target=_blank style='color:#2F92EE;'>#Solbinsiran#</a>, objectTitle=The Lancet：降脂界革命？靶向ANGPTL3新藥顯神威，甘油三酯、壞膽固醇雙雙銳減！, objectType=article, longId=870598, objectId=7ddf8e059877, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, objectUrl=/article/show_article.do?id=7ddf8e059877, replyNumber=0, likeNumber=35, createdTime=2025-04-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ddf8e059877, moduleTitle=The Lancet：降脂界革命？靶向ANGPTL3新藥顯神威，甘油三酯、壞膽固醇雙雙銳減！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7ddf8e059877)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-05
